Outcome of ischemic stroke patients with serious post-thrombolysis neurological deficits

Acta Neurologica Scandinavica

Volumn 127, Issue 4, 2013, Pages 221-226

  Strbian, Daniel ^a   Atula, Sari ^a   Meretoja, Atte ^a   Kaste, Markku ^a   Tatlisumak, Turgut ^a   Ville, Artto ^a   Sami, Curtze ^a   Olli, Häppölä ^a   Ron, Liebkind ^a   Perttu, Lindsberg ^a   Satu, Mustanoja ^a   Katja, Piironen ^a   Janne, Pitkäniemi ^a   Jukka, Putaala ^a   Kirsi, Rantanen ^a   Tiina, Sairanen ^a   Oili, Salonen ^a   Heli, Silvennoinen ^a   Lauri, Soinne ^a   Marjaana, Tiainen ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Intravenous thrombolysis; Ischemic stroke; Neurological deficit; Prognosis

Indexed keywords

ALTEPLASE; GLUCOSE;

ADULT; AGED; ARTICLE; BRAIN ISCHEMIA; COMPUTER ASSISTED TOMOGRAPHY; CONGESTIVE HEART FAILURE; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; FEMALE; GLUCOSE BLOOD LEVEL; HEART ATRIUM FIBRILLATION; HUMAN; HYPERLIPIDEMIA; MAJOR CLINICAL STUDY; MALE; MECHANICAL THROMBECTOMY; MEDICAL HISTORY; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; NEUROLOGIC DISEASE; OUTCOME ASSESSMENT; RANKIN SCALE; STROKE PATIENT; SYSTOLIC BLOOD PRESSURE; TIME TO TREATMENT;

AGE FACTORS; AGED; AGED, 80 AND OVER; FEMALE; FIBRINOLYTIC AGENTS; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NERVOUS SYSTEM DISEASES; SEVERITY OF ILLNESS INDEX; STROKE; TREATMENT OUTCOME;

EID: 84875069093     PISSN: 00016314     EISSN: 16000404     Source Type: Journal    
DOI: 10.1111/j.1600-0404.2012.01698.x     Document Type: Article

References (22)

1. Rha JH, Saver JL. The impact of recanalization on ischemic stroke outcome: a meta-analysis. Stroke 2007;38:967-73.
2. Appelboom G, Strozyk D, Meyers PM, Higashida RT. Current recommendations for endovascular interventions in the treatment of ischemic stroke. Curr Atheroscler Rep 2010;12:244-50.
3. Saqqur M, Uchino K, Demchuk AM et al. Site of arterial occlusion identified by transcranial Doppler predicts the response to intravenous thrombolysis for stroke. Stroke 2007;38:948-54.
4. Furlan AJ, Higashida R, Wechsler L et al. Intra-arterial prourokinase for acute ischemic stroke: the PROACT II study-A randomized controlled trial: prolyse in Acute Cerebral Thromboembolism. JAMA 1999;282:2003-11.
5. Smith WS, Sung G, Starkman S et al. Safety and efficacy of mechanical embolectomy in acute ischemic stroke: results of the MERCI trial. Stroke 2005;36:1432-8.
6. The Penumbra Pivotal Stroke Trial Investigators. The penumbra pivotal stroke trial: safety and effectiveness of a new generation of mechanical devices for clot removal in intracranial large vessel occlusive disease. Stroke 2009;40:2761-8.
7. Molina CA. Futile recanalization in mechanical embolectomy trials: a call to improve selection of patients for revascularization. Stroke 2010;41:842-3.
8. Ogawa A, Mori E, Minematsu K et al. Randomized trial of intraarterial infusion of urokinase within 6 hours of middle cerebral artery stroke: the middle cerebral artery embolism local fibrinolytic intervention trial (MELT) Japan. Stroke 2007;38:2633-9.
9. Meretoja A, Putaala J, Tatlisumak T et al. Off-label thrombolysis is not associated with poor outcome in patients with stroke. Stroke 2010;41:1450-8.
10. Lindsberg PJ, Soinne L, Tatlisumak T et al. Long-term outcome after intravenous thrombolysis of basilar artery occlusion. JAMA 2004;292:1862-6.
11. Smith WS, Sung G, Saver J et al. Mechanical thrombectomy for acute ischemic stroke: final results of the Multi MERCI trial. Stroke 2008;39:1205-12.
12. Hacke W, Kaste M, Fieschi C et al. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Lancet 1998;352:1245-51.
13. Brown DL, Johnston KC, Wagner DP, Haley EC Jr. Predicting major neurological improvement with intravenous recombinant tissue plasminogen activator treatment of stroke. Stroke 2004;35:147-50.
14. Grotta JC, Welch KM, Fagan SC et al. Clinical deterioration following improvement in the NINDS rt-PA stroke trial. Stroke 2001;32:661-8.
15. Molina CA, Alexandrov AV, Demchuk AM, Saqqur M, Uchino K, Alvarez-Sabin J. Improving the predictive accuracy of recanalization on stroke outcome in patients treated with tissue plasminogen activator. Stroke 2004;35:151-6.
16. Putaala J, Sairanen T, Meretoja A et al. Post-thrombolytic hyperglycemia and 3-month outcome in acute ischemic stroke. Cerebrovasc Dis 2010;31:83-92.
17. Flint AC, Duckwiler GR, Budzik RF, Liebeskind DS, Smith WS. Mechanical thrombectomy of intracranial internal carotid occlusion: pooled results of the MERCI and multi MERCI part I trials. Stroke 2007;38:1274-80.
18. Khatri P, Hill MD, Palesch YY et al. Methodology of the interventional management of stroke III trial. Int J Stroke 2008;3:130-7.
19. Loh Y, Kim D, Shi ZS et al. Higher rates of mortality but not morbidity follow intracranial mechanical thrombectomy in the elderly. AJNR Am J Neuroradiol 2010;31:1181-5.
20. Mazighi M, Serfaty JM, Labreuche J et al. Comparison of intravenous alteplase with a combined intravenous-endovascular approach in patients with stroke and confirmed arterial occlusion (RECANALISE study): a prospective cohort study. Lancet Neurol 2009;8:802-9.
21. Rubiera M, Ribo M, Pagola J et al. Bridging intravenous-intra-arterial rescue strategy increases recanalization and the likelihood of a good outcome in nonresponder intravenous tissue plasminogen activator-treated patients: a case-control study. Stroke 2011;42:993-7.
22. Strbian D, Meretoja A, Ahlhelm FA et al. Predicting outcome of IV thrombolysis-treated ischemic stroke patients: the DRAGON score. Neurology 2012;78:427-32.